AGP
Artia Global Partners Portfolio holdings
AUM
$622M
1-Year Est. Return
234.78%
This Fund
S&P 500
1 Year Est. Return
+234.78%
AUM
$622M
AUM Growth
+$54.1M
(+9.5%)
Holding
67
Top Buys
| 1 | +$40.9M | |
| 2 | +$20.8M | |
| 3 | +$20.3M | |
| 4 |
uniQure
QURE
|
+$14.1M |
| 5 |
CDTX
Cidara Therapeutics
CDTX
|
+$11.4M |
Top Sells
| 1 | +$40.4M | |
| 2 | +$27.9M | |
| 3 | +$21.6M | |
| 4 |
Boston Scientific
BSX
|
+$17.9M |
| 5 |
argenx
ARGX
|
+$11.7M |
Sector Composition
| 1 | Healthcare | 96.06% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alector
ALEC
$242M
| – | – |
-71,029
|
|
||
52
Biohaven
BHVN
$1.35B
| – | – |
-80,000
|
|
||
|
53
Boston Scientific
BSX
$107B
| – | – |
-183,200
|
|
||
|
CNTA
54
Centessa Pharmaceuticals
CNTA
$3.86B
| – | – |
-133,291
|
|
||
55
Iris Energy
IREN
$12.9B
| – | – |
-33,200
|
|
||
56
KalVista Pharmaceuticals
KALV
$874M
| – | – |
-41,555
|
|
||
|
MREO
57
Mereo BioPharma
MREO
$62.3M
| – | – |
-475,361
|
|
||
58
Moderna
MRNA
$22B
| – | – |
-23,800
|
|
||
|
MRUS
59
DELISTED
Merus
MRUS
| – | – |
-296,750
|
|
||
60
Nektar Therapeutics
NKTR
$1.93B
| – | – |
-57,999
|
|
||
61
Ultragenyx Pharmaceutical
RARE
$2.18B
| – | – |
-64,502
|
|
||
62
Regeneron Pharmaceuticals
REGN
$82.6B
| – | – |
-10,671
|
|
||
63
Sarepta Therapeutics
SRPT
$1.85B
| – | – |
-44,900
|
|
||
64
TG Therapeutics
TGTX
$4.66B
| – | – |
-54,515
|
|
||
|
VRNA
65
DELISTED
Verona Pharma
VRNA
| – | – |
-379,004
|
|
||
66
Vertex Pharmaceuticals
VRTX
$117B
| – | – |
-55,100
|
|
||
|
ATYR
67
aTyr Pharma
ATYR
$88.1M
| – | – |
-372,276
|
|